Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC309557PMC
http://dx.doi.org/10.1093/nar/21.10.2514DOI Listing

Publication Analysis

Top Keywords

bsp1407i restriction
4
restriction endonuclease
4
endonuclease bacillus
4
bacillus stearothermophilus
4
stearothermophilus recognizes
4
recognizes novel
4
novel palindromic
4
palindromic sequence
4
sequence 5'-t
4
5'-t decreases
4

Similar Publications

Background: We describe the potentiation of antiproliferative and apoptotic activities triggered by cis-diamminedichloroplatinum(II) (DDP), and obtained in vitro by the co-administration of procainamide hydrochloride (PdHCl) in murine P388, and human A2780 and A549 cells.

Methods: We determined the antiproliferative and apoptotic activities of DDP and PdHCl combinations by different techniques. Moreover, cell cycle analysis, restriction enzyme inhibition followed by agarose gel electrophoresis, and TUNEL analysis of tumour cells in vivo were also used to strengthen our hypothesis.

View Article and Find Full Text PDF

Development of a PCR-RFLP assay for the detection and differentiation of canine parvovirus and mink enteritis virus.

J Virol Methods

December 2014

Shandong Key Laboratory of Preventive Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China. Electronic address:

A polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay has been developed to detect and differentiate between canine parvovirus (CPV) and mink enteritis virus (MEV). Eight CPV and three MEV epidemic strains isolated from 28 pathological samples from dogs and minks suspected of being infected with parvovirus were amplified by PCR using a pair of specific primers designed based on the CPV-N strain (M19296). PCR amplified a fragment of 1016bp from the genomic DNA of both MEV and CPV.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!